Clinical application of FDG-PET/CT in metastatic infections

被引：13

作者：

Kouijzer, Ilse J. ^{[1
]}

Vos, Fidel J. ^{[1
,2
]}

Bleker-Rovers, Chantal P. ^{[1
]}

Oyen, Wim J. ^{[3
]}

机构：

[1] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, POB 9101, Nijmegen, Netherlands

[2] Sint Maartensklin, Nijmegen, Netherlands

[3] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands

来源：

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 61卷 / 02期

关键词：

Fluorodeoxyglucose F18; Positron-emission tomography; Computed tomography; Metastatic infection; Bacteremia; Diagnostic imaging; POSITRON-EMISSION-TOMOGRAPHY; STAPHYLOCOCCUS-AUREUS BACTEREMIA; AORTIC GRAFT INFECTION; VASCULAR PROSTHESIS INFECTION; F-18-FDG PET/CT; VERTEBRAL OSTEOMYELITIS; LEUKOCYTE SCINTIGRAPHY; DIAGNOSIS; MANAGEMENT; VALVE;

D O I：

10.23736/S1824-4785.16.02735-7

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

FDG-PET/CT has proven its clinical value and cost-effectiveness in diagnosing metastatic infections in patients with Gram-positive bacteremia. In identification of metastatic foci, FDG-PET/CT is useful as a screening method when localizing symptoms are absent because it provides whole-body coverage. FDG-PET/CT detects early metabolic activity rather than the late anatomical changes as visualized by computed tomography and magnetic resonance imaging. FDG-PET/CT allows more precise localization of infection within a shorter time span between injection and diagnosis as compared to conventional nuclear imaging. This review focuses on the clinical application of imaging of metastatic infectious diseases, with an emphasis on FDG-PET/CT putting it in perspective with other imaging modalities.

引用

页码：232 / 246

页数：15

共 50 条

[1] FDG-PET/CT in infections: the imaging method of choice?
Glaudemans, Andor W. J. M.
Signore, Alberto
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) : 1986 - 1991
[2] FDG-PET in Prosthetic Graft Infections
Keidar, Zohar
Nitecki, Samy
SEMINARS IN NUCLEAR MEDICINE, 2013, 43 (05) : 396 - 402
[3] Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update
Bezzi, Davide
Ambrosini, Valentina
Nanni, Cristina
SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (03) : 352 - 370
[4] FDG-PET/CT in venous thromboembolism
Hess, Soren
Frary, Evan C.
Gerke, Oke
Werner, Tom
Alavi, Abass
Hoilund-Carlsen, Poul F.
CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (05) : 369 - 378
[5] FDG-PET in Musculoskeletal Infections
Palestro, Christopher J.
SEMINARS IN NUCLEAR MEDICINE, 2013, 43 (05) : 367 - 376
[6] FDG-PET in Cardiac Infections
Erba, Paola A.
Sollini, Martina
Lazzeri, Elena
Mariani, Giuliano
SEMINARS IN NUCLEAR MEDICINE, 2013, 43 (05) : 377 - 395
[7] FDG-PET/CT and new radiopharmaceuticals in patients with multiple myeloma
Morales Lozano, M. I.
Garcia-Velloso, M. J.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (02): : 129 - 135
[8] The role of FDG-PET/CT in gynaecological cancers
Rockall, Andrea G.
Cross, Susan
Flanagan, Sean
Moore, Elizabeth
Avril, Norbert
CANCER IMAGING, 2012, 12 (01): : 49 - 65
[9] FDG-PET/CT of COVID-19 and Other Lung Infections
Eibschutz, Liesl S.
Rabiee, Behnam
Asadollahi, Shadi
Gupta, Amit
Assadi, Majid
Alavi, Abass
Gholamrezanezhad, Ali
SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (01) : 61 - 70
[10] Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease
Kim, Min-Sun
Kim, Eun-Kyung
Choi, Joon Young
Oh, Jae K.
Chang, Sung-A
CURRENT CARDIOLOGY REPORTS, 2019, 21 (09)

← 1 2 3 4 5 →